Agentix (AGTX) Return on Assets (2014 - 2026)
Agentix's (AGTX) quarterly Return on Assets came in at 1.36% in Q1 2026, down 131.0% YoY from 4.37% in Q1 2025, and down 37.71% on a QoQ basis from 0.98% in Q4 2025.
Agentix (AGTX) Return on Assets (2014 - 2026) Analysis & Trends
Agentix (AGTX) has 13 years of Return on Assets data on file, last reported at 1.36% in Q1 2026.
- Quarterly Return on Assets fell 131.0% year-over-year to 1.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.36% (down 131.0% YoY) and the FY2026 annual result came in at 0.1%, down 4.0% from the prior year.
- Return on Assets declined to 1.36% in Q1 2026, from 0.98% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.01% in Q3 2024 to a low of 2.84% in Q3 2022.
- A 5-year average of 0.5% and a median of 0.07% in 2023 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2023 — Return on Assets surged 279 bps — and 2026, when it plunged 131 bps.
- Tracing AGTX's Return on Assets over 5 years: stood at 0.49% in 2022, then soared by 91 bps to 0.05% in 2023, then surged by 47 bps to 0.02% in 2024, then tumbled by 4007 bps to 0.98% in 2025, then slumped by 38 bps to 1.36% in 2026.
- The last three Return on Assets figures came in at 1.36% (Q1 2026), 0.98% (Q4 2025), and 1.31% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | -10.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.32% |
| Mar 31, 2026 | -1.36% |
| Dec 31, 2025 | -0.98% |
| Sep 30, 2025 | -1.31% |
| Jun 30, 2025 | -0.12% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.05% |
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.05% |
| Mar 31, 2023 | -0.07% |
| Dec 31, 2022 | -0.49% |
| Sep 30, 2022 | -2.84% |
| Jun 30, 2022 | -0.66% |
| Feb 28, 2022 | -0.44% |
| Nov 30, 2021 | -0.25% |
| Aug 31, 2021 | -0.25% |